» Articles » PMID: 18483755

Factors Associated with Mortality in Patients with Bloodstream Infection and Pneumonia Due to Stenotrophomonas Maltophilia

Overview
Publisher Springer
Date 2008 May 17
PMID 18483755
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Severe infections caused by Stenotrophomonas maltophilia are associated with high mortality, and strategies to improve the clinical outcome for infected patients are needed. A retrospective cohort study of patients with bloodstream infection (BSIs) and pneumonia caused by S. maltophilia was conducted. Multivariate analysis was performed to access factors associated with 14-day mortality. A total of 60 infections were identified. Among these, eight (13%) were pneumonias and 52 were BSIs; 33.3% were primary, 13% were central venous catheter (CVC)-related and 40% were secondary BSIs. Fifty-seven (85%) patients had received previous antimicrobial therapy; 88% had CVC, 57% mechanical ventilation and 75% were in the intensive care unit at the onset of infection. Malignancy (45%) was the most frequent underlying disease. The mean of the Acute Physiology and Chronic Health Evaluation II (APACHE II) scores was 17 and for the Sepsis-related Organ Failure Assessment (SOFA) score, it was 7 points. The overall and 14-day mortality were, respectively, 75% and 48%. Forty-seven (78%) patients were treated and, of these, 74% received trimethoprim-sulfamethoxazole. Independent risk factors associated with mortality were SOFA index >6 points (0.005) and septic shock (0.03). The Kaplan-Meier estimations curves showed that patients with APACHE II score >20 and SOFA score >10 had a survival chance of, respectively, less than 8% and less than 10% (P<or=0.001) at 21 days after the first positive S. maltophilia culture. Our results suggest that the independent factors associated with outcome in patients with infection caused by S. maltophilia are septic shock and higher SOFA index.

Citing Articles

Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review.

Vena A, Mezzogori L, Castaldo N, Corcione S, Pascale R, Giannella M Infect Dis Ther. 2025; .

PMID: 40032812 DOI: 10.1007/s40121-025-01117-2.


Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014-2021.

Wang H, Li S, Ji H, Hu Y, Zhou S, Chen X Infect Dis Ther. 2024; 14(1):261-274.

PMID: 39731666 PMC: 11782787. DOI: 10.1007/s40121-024-01099-7.


Bacteremia: From Diagnosis to Treatment.

Aysert-Yildiz P, Yildiz Y, Habibi H, Eser S, Ozgen-Top O, Ozger H Infect Dis Clin Microbiol. 2024; 4(4):258-267.

PMID: 38633723 PMC: 10986728. DOI: 10.36519/idcm.2022.187.


Comparisons of the Oral Microbiota from Seven Species of Wild Venomous Snakes in Taiwan Using the High-Throughput Amplicon Sequencing of the Full-Length 16S rRNA Gene.

Lin W, Tsai T Biology (Basel). 2023; 12(9).

PMID: 37759605 PMC: 10525742. DOI: 10.3390/biology12091206.


Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group.

Saburi M, Oshima K, Takano K, Inoue Y, Harada K, Uchida N Ann Hematol. 2023; 102(9):2507-2516.

PMID: 37338625 DOI: 10.1007/s00277-023-05320-4.


References
1.
Toro M, Rodriguez-Bano J, Herrero M, Rivero A, Corzo J . Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine (Baltimore). 2002; 81(3):228-39. DOI: 10.1097/00005792-200205000-00006. View

2.
Wang W, Liu C, Lee C, Huang F . Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004; 37(6):359-65. View

3.
Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S . Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000; 31(3):705-11. DOI: 10.1086/314043. View

4.
Lai C, Chi C, Chen H, Chen T, Lai C, Fung C . Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004; 37(6):350-8. View

5.
Garner J, Jarvis W, Emori T, Horan T, Hughes J . CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3):128-40. DOI: 10.1016/0196-6553(88)90053-3. View